Drug Profile
Research programme: gene-based therapeutics and diagnostics - Human Genome Sciences/Amgen
Alternative Names: Autoimmune disorder therapies - Human Genome Sciences/Amgen; Cancer therapies - Human Genome Sciences/Amgen; Diagnostic products - Human Genome Sciences/AmgenLatest Information Update: 05 Sep 2008
Price :
$50
*
At a glance
- Originator Human Genome Sciences
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer
Most Recent Events
- 05 Sep 2008 No development reported - Preclinical for Autoimmune disorders in USA (unspecified route)
- 05 Sep 2008 No development reported - Preclinical for Cancer diagnosis in USA (unspecified route)
- 05 Sep 2008 No development reported - Preclinical for Cancer in USA (unspecified route)